Alnylam Pharmaceuticals Inc Headquarters
The links below provide all the necessary information about Alnylam Pharmaceuticals Inc Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Contact Alnylam® Pharmaceuticals
- https://www.alnylam.com/contact-us
- 11th Floor of Pacific Century Place Marunouchi 1-11-1 Marunouchi, Chiyoda-ku Tokyo 100-6211 Japan Tel: 0120.970.347
Alnylam Pharmaceuticals Corporate Headquarters, Office ... - Craft
- https://craft.co/alnylam-pharmaceuticals/locations
- Alnylam Pharmaceuticals headquarters and office locations. Alnylam Pharmaceuticals is headquartered in Cambridge, MA and has 7 office locations across 7 countries. ... All Alnylam Pharmaceuticals Locations. Cambridge (HQ), MA. United States. 675 W Kendall St. Paris. France. 100 Av. de Suffren. Milano. Italy. Via Pola, 11. Amsterdam.
Alnylam Pharmaceuticals Company Profile | Management and …
- https://www.datanyze.com/companies/alnylam-pharmaceuticals/10034211
- Alnylam Pharmaceuticals headquarters are located in 675 West Kendall St, Cambridge, Massachusetts, 02142, United States ... Alnylam Pharmaceuticals Inc, Alnylam Pharmaceuticals ALNYLAM PHARMACEUTICALS, INC., Alnylam...See More. Start with Datanyze For Free! Find your B2B customer within minutes using affordable, accurate contact data from Datanyze.
Alnylam Pharmaceuticals Company Profile - Craft
- https://craft.co/alnylam-pharmaceuticals
- Alnylam Pharmaceuticals has 1,323 employees across 7 locations and $492.85 M in annual revenue in FY 2020. See insights on Alnylam Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Alnylam Pharmaceuticals - Crunchbase Company Profile …
- https://www.crunchbase.com/organization/alnylam-pharmaceuticals
- Contact Email [email protected]. Phone Number 617.551.8200. Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases.
Alnylam Pharmaceuticals, Inc. Company Profile - Dun
- https://www.dnb.com/business-directory/company-profiles.alnylam_pharmaceuticals_inc.f77aeac5497827e6196179962b069807.html
- Company Description: Like a genetic linebacker, Alnylam Pharmaceuticals runs interference with RNA to prevent the forward progress of disease. RNA interference (RNAi) technology developed by the biotech firm can selectively shut off harmful genes. The company is developing a pipeline of candidates both individually and through collaborations with other drugmakers.
Alnylam Pharmaceuticals email address and contacts
- https://getprospect.com/business-directory/alnylam
- Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring RNAi-based medicines to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases.
Alnylam Pharmaceuticals Inc - Company Profile and …
- https://www.bloomberg.com/profile/company/ALNY:US
- Company profile page for Alnylam Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information
Investor Relations | Alnylam Pharmaceuticals, Inc.
- https://investors.alnylam.com/
- The Investor Relations website contains information about Alnylam Pharmaceuticals, Inc.'s business for shareholders, potential investors, and financial analysts.
Alnylam Pharmaceuticals Inc. - Company Profiles - BCIQ
- https://profiles.biocentury.com/companies/alnylam_pharmaceuticals_inc
- Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), that company’s first approved drug and the first RNAi therapy to gain FDA’s approval. Alnylam ’s.....million in a follow-on.TARGETSHAO1 - Hydroxyacid oxidase 1KLKB1 – Plasma kallikreinTTR – Transthyretin Paul Bonanos NTLA-2001 Intellia Therapeutics Inc. Alnylam Pharmaceuticals Inc. Beam...
Alnylam (ALNY) Stock Information | Alnylam Pharmaceuticals, Inc.
- https://investors.alnylam.com/alny-stock-information
- Stock information. Alnylam trades on the NASDAQ Stock Market under the symbol ALNY. container. container-970 mb-65 stock-chart. ALNY Chart by TradingView. grey-bg padding-top-bottom-65. container. container-970 d-flex flex-1.
Alnylam Pharmaceuticals (ALNY) - Forbes
- https://www.forbes.com/companies/alnylam-pharmaceuticals/
- Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. ... Headquarters Cambridge ...
Did you find out everything you wanted about Alnylam Pharmaceuticals Inc Headquarters?
We are sure that the information collected for you about Alnylam Pharmaceuticals Inc Headquarters turned out to be more than enough.
